ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Stoke Therapeutics Inc

Stoke Therapeutics Inc (STOK)

11.42
0.11
( 0.97% )
Updated: 11:27:06

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
11.42
Bid
11.42
Ask
11.46
Volume
49,375
11.13 Day's Range 11.47
3.77 52 Week Range 17.58
Market Cap
Previous Close
11.31
Open
11.26
Last Trade
2
@
11.4215
Last Trade Time
11:27:49
Financial Volume
$ 558,254
VWAP
11.3064
Average Volume (3m)
577,616
Shares Outstanding
52,966,977
Dividend Yield
-
PE Ratio
-5.65
Earnings Per Share (EPS)
-1.98
Revenue
8.78M
Net Profit
-104.7M

About Stoke Therapeutics Inc

Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively... Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Dover, Delaware, USA
Founded
-
Stoke Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker STOK. The last closing price for Stoke Therapeutics was $11.31. Over the last year, Stoke Therapeutics shares have traded in a share price range of $ 3.77 to $ 17.58.

Stoke Therapeutics currently has 52,966,977 shares outstanding. The market capitalization of Stoke Therapeutics is $599.06 million. Stoke Therapeutics has a price to earnings ratio (PE ratio) of -5.65.

STOK Latest News

Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates

– Company plans to provide seizure as well as cognition and behavior data from all patients treated with initial 70mg doses followed by 45mg maintenance dosing in studies of zorevunersen by...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.58-18.42857142861414.7211.0871636312.24010199CS
4-0.74-6.0855263157912.1614.7211.0846643012.75221633CS
12-2.42-17.485549132913.8416.1511.0857761613.29118466CS
26-4.5-28.266331658315.9217.5811.0859049113.96723414CS
527.3177.1844660194.1217.583.7769135112.200801CS
156-17.88-61.02389078529.333.06353.3542958112.21706887CS
260-12.6-52.45628642824.0271.583.3531894816.40445594CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WORXSCWorx Corporation
$ 2.0002
(104.10%)
106.67M
CRNCCerence Inc
$ 4.865
(72.52%)
34.06M
BDRXBiodexa Pharmaceuticals PLC
$ 5.42
(40.78%)
4.53M
IBGInnovation Beverage Group Limited
$ 1.1122
(40.57%)
7.43M
SPAISafe Pro Group Inc
$ 4.41
(37.81%)
38.6M
GLXGGalaxy Payroll Group Ltd
$ 1.90
(-51.41%)
685.65k
PYXSPyxis Oncology Inc
$ 2.055
(-46.20%)
9.73M
KURAKura Oncology Inc
$ 10.065
(-36.74%)
7.85M
BLRXBioLineRx Ltd
$ 0.3527
(-35.31%)
6.01M
SHOTWSafety Shot Inc
$ 0.1001
(-33.27%)
2.5k
CDTConduit Pharmaceuticals Inc
$ 0.1123
(21.67%)
498.03M
NVDANVIDIA Corporation
$ 143.80
(-1.43%)
210.92M
AKTSAkoustis Technologies Inc
$ 0.1017
(16.76%)
184.08M
ELABElevai Labs Inc
$ 0.0202
(-5.61%)
163.78M
WORXSCWorx Corporation
$ 2.0002
(104.10%)
106.67M

Your Recent History

Delayed Upgrade Clock